Phase I/II study of weekly PM00104 (Zalypsis®) in patients with relapsed/refractory multiple myeloma
Ocio, Enrique M., Oriol, Albert, Bladé, Joan, Teruel, Ana I., Martín, Jesus, Rubia, Javier, Gutiérrez, Norma C., Rodríguez Díaz‐Pavón, José, Martínez González, Sara, Coronado, Cinthya, Fernández‐García, Eva M., Siguero Gómez, Mariano, Fernández‐Teruel, Carlos, San Miguel, Jesus
Published in British journal of haematology (01.02.2016)
Published in British journal of haematology (01.02.2016)
Get full text
Journal Article
Phase I study of elisidepsin (Irvalec®) in combination with carboplatin or gemcitabine in patients with advanced malignancies
Goldwasser, Francois, Faivre, Sandrine, Alexandre, Jerome, Coronado, Cinthya, Fernández-García, Eva M., Kahatt, Carmen M., Paramio, Pilar García, Dios, Jorge Luis Iglesias, Miguel-Lillo, Bernardo, Raymond, Eric
Published in Investigational new drugs (01.06.2014)
Published in Investigational new drugs (01.06.2014)
Get full text
Journal Article
Phase I, dose-escalating study of elisidepsin (Irvalec®), a plasma membrane-disrupting marine antitumor agent, in combination with erlotinib in patients with advanced malignant solid tumors
Goel, Sanjay, Viteri, Santiago, Morán, Teresa, Coronado, Cinthya, Dios, Jorge Luis Iglesias, Miguel-Lillo, Bernardo, Fernández-García, Eva M., Rosell, Rafael
Published in Investigational new drugs (01.02.2016)
Published in Investigational new drugs (01.02.2016)
Get full text
Journal Article
Phase 2 Study of Trabectedin in Patients With Hormone Receptor–Positive, HER-2–Negative, Advanced Breast Carcinoma According to Expression of Xeroderma Pigmentosum G Gene
Awada, Ahmad, Cortés, Javier, Martín, Miguel, Aftimos, Philippe, Oliveira, Mafalda, López-Tarruella, Sara, Espie, Marc, Lardelli, Pilar, Extremera, Sonia, Fernández-García, Eva M, Delaloge, Suzette
Published in Clinical breast cancer (01.10.2016)
Published in Clinical breast cancer (01.10.2016)
Get full text
Journal Article